Cargando…
Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population‐based study and review of literature
BACKGROUNDS: Nonalcoholic fatty liver disease (NAFLD) is linked to obesity and metabolic syndrome conditions. However, a subset of NAFLD patients express a normal or low body mass index (lean NAFLD [L‐NAFLD]). Our aim is to compare the prevalence of L‐NAFLD to the obesity‐associated NAFLD in the Uni...
Autores principales: | Almomani, Ashraf, Kumar, Prabhat, Onwuzo, Somtochukwu, Boustany, Antoine, Krishtopaytis, Eduard, Hitawala, Asif, Alshaikh, Dana, Albakri, Almaza, Hussein, Leen, Hussein, Ebrahim, Asaad, Imad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098473/ https://www.ncbi.nlm.nih.gov/pubmed/36328950 http://dx.doi.org/10.1111/jgh.16049 |
Ejemplares similares
-
Cirrhotic patients on proton pump inhibitors are at a twofold risk of spontaneous bacterial peritonitis independently of gastrointestinal bleeding: a population-based retrospective study
por: Boustany, Antoine, et al.
Publicado: (2023) -
Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study
por: Onwuzo, Somtochukwu Stephen, et al.
Publicado: (2023) -
Epidemiology and risk of colorectal cancer in patients with a history of Helicobacter pylori infection: a population-based study
por: Boustany, Antoine, et al.
Publicado: (2023) -
Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study
por: Onwuzo, Somtochukwu, et al.
Publicado: (2023) -
Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study
por: Almomani, Ashraf, et al.
Publicado: (2022)